作者：
Pallawi,Torka [1]
;
Shalin K,Kothari [2]
;
Suchitra,Sundaram [1]
;
Shaoying,Li [3]
;
L Jeffrey,Medeiros [3]
;
Emily C,Ayers [4]
;
Daniel J,Landsburg [4]
;
David A,Bond [5]
;
Kami J,Maddocks [5]
;
Anshu,Giri [6]
;
Brian,Hess [6]
;
Luu Q,Pham [7]
;
Ranjana,Advani [7]
;
Yang,Liu [8]
;
Stefan Klaus,Barta [8]
;
Julie M,Vose [9]
;
Michael C,Churnetski [10]
;
Jonathon B,Cohen [10]
;
Madelyn,Burkart [11]
;
Reem,Karmali [11]
;
Joanna,Zurko [12]
;
Amitkumar,Mehta [12]
;
Adam J,Olszewski [13]
;
Sarah,Lee [14]
;
Brian T,Hill [14]
;
Timothy F,Burns [15]
;
Frederick,Lansigan [15]
;
Emma,Rabinovich [16]
;
David,Peace [16]
;
Adrienne,Groman [1]
;
Kristopher,Attwood [1]
;
Francisco J,Hernandez-Ilizaliturri [1]
作者单位：
Roswell Park Comprehensive Cancer Center, Buffalo, NY.
[1]
Department of Medicine, Yale University, New Haven, CT.
[2]
The University of Texas MD Anderson Cancer Center, Houston, TX.
[3]
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
[4]
The Ohio State University Cancer Center, Columbus, OH.
[5]
Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC.
[6]
Lymphoma Division, Stanford University, Stanford, CA.
[7]
Fox Chase Cancer Center, Philadelphia, PA.
[8]
University of Nebraska Medical Center, Omaha, NE.
[9]
Winship Cancer Institute, Emory University, Atlanta, GA.
[10]
Feinberg School of Medicine, Northwestern University, Chicago, IL.
[11]
Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
[12]
Department of Medicine, Alpert Medical School, Brown University, Providence, RI.
[13]
Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH.
[14]
Dartmouth-Hitchcock Medical Center, Lebanon, NH; and.
[15]
Division of Hematology & Oncology, University of Illinois at Chicago, Chicago, IL.
[16]
DOI
10.1182/bloodadvances.2019000875
PMID
31945157
发布时间
2021-09-25
换一批
换一批
